Cefoxitin is a new semisynthetic cephamycin which is highly resistant to ,@-lactamases from gram-positive and gram-negative bacteria (6) . This property certainly accounts for some, but probably not all (6) , of the effectiveness of cefoxitin against cephalothin-resistant organisms which has been demonstrated in preliminary studies (2, 6, 9) . These studies suggest that cefoxitin has a broader spectrum of activity than cephalothin, but to date this has not been confirmed with tests of cefoxitin susceptibility of a large series of unselected clinical isolates. We have recently had the opportunity to determine the cefoxitin susceptibility of a large number (4, 929) of clinical isolates of bacteria submitted to our laboratory for routine testing. Antibiotic susceptibilities were determined by the single-disk method in conjunction with a computer-associated electronic zone analyzer (4) . The latter was utilized for performing, storing, and analyzing measurements of zones of inhibition.
MATERIALS AND METHODS
Bacteria used in this study were tive bacilli, a larger percentage was susceptible to cefoxitin than to cephalothin. This difference was particularly striking for Flavobacter sp., indole-positive Proteus sp., Providence sp., and Serratia sp., among which more than 50% of strains resistant to cephalothin were susceptible to cefoxitin. Although the differences were not as great, cefoxitin was also more effective against Escherichia coli, Klebsiella sp., Pseudomonas maltophilia, Herellea vaginicola, and Mima polymorpha. Between 6 and 18% of these strains which were resistant to cephalothin were susceptible to cefoxitin. Among the Bacteroides sp., the majority of strains were resistant to both cephalothin and cefoxitin when our original zone size criteria were applied. However, when the data were recalculated using as a criterion for susceptibility a zone diameter of 24 mm or greater (which corresponds to an MIC of 25 ,g/ml or less), 44% of the strains were susceptible to cefoxitin as compared with 5% to cephalothin.
Quantitative differences in susceptibility of various organisms to cephalothin and cefoxitin can be shown quite clearly by comparing computer-generated plots of the distribution of zones of inhibition produced by each agent (5) . Figure 1 shows the superimposition of the computer-generated plots of the distribution of zones of inhibition produced by 30-,Ag cefoxitin and cephalothin disks against Proteus morganii. The enhanced activity of cefoxitin against this strain is demonstrated by the fact that the curve for cefoxitin is shifted to the right of that for cephalothin (i.e., cefoxitin produced generally larger zones of inhibition). Similar plots were made for the other organisms tested. To conserve space and to make interpretation easier, a number of these zone size distributions have been converted to line drawings and incorporated in Fig. 2 and 3 .
In general, cephalothin produced larger zones than cefoxitin against staphylococci (Fig. 2) . The situation was strikingly different for the enterococci, however. Cefoxitin elicited no zone of inhibition (diameter of disk, 6 mm) against 96% of the enterococci, whereas the majority of these organisms were inhibited to a greater or lesser degree by cephalothin. Although the overall pattems of distribution of zones of inhibition for cephalothin and cefoxitin were similar against E. coli, the curve for cefoxitin was shifted to the right of that for cephalothin, confirming that a number of strains resistant to cephalothin were susceptible to cefoxitin. The two antibiotics produced nearly identical pattems against Klebsiella sp. The zone size distri- butions similarly revealed that there was little difference between the effectiveness of cephalothin and cefoxitin against Proteus mirabilis. However, the markedly increased activity of cefoxitin against all indole-positive Proteus strains tested is clearly shown in Fig. 3 . Likewise, these distributions of zone diameters illustrate the increased susceptibility of Providence of unselected clinical isolates of bacteria. Cefoxitin was active against staphylococci and all streptococci except enterococci, although the zones of inhibition among the gram-positive strains were generally larger with cephalothin than with cefoxitin. This suggests that although the majority of strains are susceptible to both agents cephalothin may be more effective against gram-positive strains. The resistance of enterococci to cefoxitin was striking and appeared so consistently that it might prove useful as an additional marker for the presumptive identification of enterococci before the results of serological and biochemical tests for speciation are available. Similar high-level resistance of enterococci to methicillin by disk testing has also been shown in our laboratory (R. C. Moellering, Jr., B. K. Watson, and L. J. Kunz, Amer. J. Med., in press).
Without exception, cefoxitin was equally as effective or more effective than cephalothin against the strains of gram-negative bacilli included in our studies. The enhanced activity of cefoxitin was particularly evident for Flavobacter sp., indole-positive Proteus sp., Providence sp., and Serratia sp. In addition, a number of strains of E. coli, Pseudomonas maltophilia, H. vaginicola, M. polymorphia, and Klebsiella sp. which were cephalothin resistant by single-disk testing were susceptible to cefoxitin. The significance of the increased susceptibility of some strains of Herellea vaginicola and Pseudomonas maltophilia to cefoxitin is unclear, since only a relatively small total number of these organisms was susceptible. However, the fact that 96% of strains of E. coli and Klebsiella sp. were cefoxitin susceptible, as compared with 83% and 90% susceptibility to cephalothin, may have clinical importance. We encountered 197 strains of E. coli which were cephalothin resistant but susceptible to cefoxitin.
The mechanism of the enhanced effectiveness of cefoxitin seems related, in part, to its marked resistance to hydrolysis by the fB-lactamases produced by a number of species of gram-negative bacilli (6) . However, this does not appear to be the entire explanation, since Onishi et al. have also shown that there is an intrinsic resistance (or basic tolerance) of certain species to cefoxitin and cephalothin which is unrelated to their ability to produce ,-lactamase (6) . This latter property may also contribute to the resistance of a given strain to cephalothin or cefoxitin. Indeed, among certain species of organisms we noted that the general pattern of distribution of sizes of zones of inhibition for cefoxitin and cephalothin were similar but not superimposed (i.e., one distribution shifted slightly to the right or left of the other). It is possible that these are examples of differences in basic tolerance of such strains to cephalothin and cefoxitin.
Cefoxitin disks produced consistently larger zones of inhibition against our Bacteroides sp. (most of which were penicillin-resistant B. fragilis) than did cephalothin disks containing equal concentrations of the drug. Using very strict criteria for susceptibility (corresponding to an MIC of 3.12 ,ug/ml or less), essentially all strains were resistant to both cephalothin and cefoxitin. However, if one utilized somewhat less stringent criteria (corresponding to an MIC of 25 Ag/ml or less, levels which can readily be achieved in blood with parenteral cephalothin therapy), almost half of the strains tested were susceptible to cefoxitin. Thus, these studies raise the possibility that cefoxitin may also be active against a significant number of strains of Bacteroides fragilis, but further studies using quantitative techniques are necessary to confirm this observation.
